Medy-Tox Incorporation operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medy-Tox Incorporation with three other
companies in this sector in South Korea:
sales of 124.19 billion Korean Won [US$110.40 million]
Choong Ang Vaccine Laboratory
(37.90 billion Korean Won [US$33.69 million]
Cell Biotech Co ., Limited.
(58.28 billion Korean Won [US$51.81 million]
of which 88%
was Finished Products).
During the year ended December of 2016, sales at
Medy-Tox Incorporation were 133.26 billion Korean Won (US$118.46 million).
increase of 50.6%
versus 2015, when the company's sales were 88.51 billion Korean Won.
This was the fifth consecutive year of sales increases at Medy-Tox Incorporation
(and since 2011, sales have increased a total of 514%).